Effect of bisphosphonate treatment on bone mineral density in patients with thalassaemia major

Keyphrases

• β-Thalassemia (β-thal) 100%
• Bone Mineral Density 100%
• Bisphosphonate Treatment 100%
• Femoral Neck 42%
• Alendronate 42%
• Lumbar Spine 28%
• Osteoporosis 28%
• Density Value 28%
• Bisphosphonate Drug 28%
• Greek Cypriots 14%
• Statistical Analysis 14%
• Treatment Completion 14%
• Thalassemia 14%
• Potent Inhibitor 14%
• Dual-energy X-ray 14%
• Treatment Protocol 14%
• Pathogenic Mechanism 14%
• Bone Disease 14%
• Bone Mass 14%
• Therapeutic Measures 14%
• Osteoclastic Bone Resorption 14%
• Bisphosphonates 14%
• Thalassemic Patients 14%
• SPSS Program 14%
• Spine Bone 14%
• Lumbar Bone Mineral Density 14%
• Hip Bone 14%

Medicine and Dentistry

• Thalassemia Major 100%
• Bisphosphonate 100%
• Bone Density 100%
• Lumbar Spine 37%
• Alendronic Acid 37%
• Femoral Neck 37%
• Pamidronic Acid 37%
• Osteoporosis 25%
• Thalassemia 12%
• Bone Mass 12%
• Osteolysis 12%
• Bone Disease 12%

Pharmacology, Toxicology and Pharmaceutical Science

• Bisphosphonic Acid Derivative 100%
• Thalassemia Major 100%
• Alendronic Acid 60%
• Pamidronic Acid 60%
• Thalassemia 20%
• Bone Disease 20%